Ivi Ryo Corp. – Trademark Portfolio

Entity Type: 03

Ivi Ryo Corp. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include MET TATHIONE and IVI PREMIUM COLLAGEN. The owner is based in Quezon City Met Manila.

E. Rodriguez Jr. Av, Barangay Bagumbayan

Quezon City Met Manila 1110 , PH

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Ivi Ryo Corp.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (1 filing)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

Frequently Asked Questions

How many trademarks does Ivi Ryo Corp. have?

Ivi Ryo Corp. has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Ivi Ryo Corp. file in?

Ivi Ryo Corp. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Ivi Ryo Corp.'s most well-known trademarks?

Ivi Ryo Corp.'s registered trademark portfolio includes well-known marks such as MET TATHIONE and IVI PREMIUM COLLAGEN. These are among 2 currently registered trademarks in the portfolio.

What is Ivi Ryo Corp.'s trademark registration success rate?

Ivi Ryo Corp. has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.